Vanessa Xanthakis, PhD

Assistant Professor, Medicine

617.638.8016
801 Massachusetts Ave Crosstown Center

Biography

Dr. Vanessa Xanthakis is a biostatistician with training in applied mathematics and statistics, and have a strong commitment to clinical epidemiological research. Presently, she is an Assistant Professor in the Section of Preventive Medicine and Epidemiology in the Department of Medicine at Boston University School of Medicine and in the Biostatistics Department at Boston University School of Public Health. At the Framingham Heart Study, she is a junior investigator and serve as the biostatistician on several investigations. For the last 8 years, Dr. Vanessa had focused her research on

A) the epidemiology of cardiac remodeling and subclinical disease, including identifying cardiovascular disease risk factors;

B) population-based vascular testing and echocardiography, including identifying biological, environmental, and genetic determinants (correlates) of cardiac structure and function;

C) epidemiology of novel biomarkers including but not limited to natriuretic peptides, adipokines, and vascular growth factors;

D) cardiovascular risk prediction using biomarkers and assessing their incremental prognostic utility (focus of her PhD thesis);

E) epidemiology of heart failure and its precursors; and

F) ideal cardiovascular health and its impact on cardiovascular disease and its precursors.

Other Positions

  • Assistant Professor, Biostatistics, Boston University School of Public Health

Education

  • Boston University School of Public Health, PhD
  • University of Athens, MS
  • University of Athens, BS

Publications

  • Published on 10/18/2018

    Echouffo-Tcheugui JB, Short MI, Xanthakis V, Field P, Sponholtz TR, Larson MG, Vasan RS. Natural History of Obesity sub-phenotypes: Dynamic changes over two decades and prognosis in The Framingham Heart Study. J Clin Endocrinol Metab. 2018 Oct 18. PMID: 30339231.

    Read at: PubMed
  • Published on 7/1/2018

    Sullivan JL, Adjognon OL, Engle RL, Shin MH, Afable MK, Rudin W, White B, Shay K, Lukas CV. Identifying and overcoming implementation challenges: Experience of 59 noninstitutional long-term services and support pilot programs in the Veterans Health Administration. Health Care Manage Rev. 2018 Jul/Sep; 43(3):193-205. PMID: 28125459.

    Read at: PubMed
  • Published on 6/21/2018

    von Jeinsen B, Short MI, Xanthakis V, Carneiro H, Cheng S, Mitchell GF, Vasan RS. Association of Circulating Adipokines With Echocardiographic Measures of Cardiac Structure and Function in a Community-Based Cohort. J Am Heart Assoc. 2018 Jun 21; 7(13). PMID: 29929991.

    Read at: PubMed
  • Published on 6/1/2018

    Nayor M, Cooper LL, Enserro DM, Xanthakis V, Larson MG, Benjamin EJ, Aragam J, Mitchell GF, Vasan RS. Left Ventricular Diastolic Dysfunction in the Community: Impact of Diagnostic Criteria on the Burden, Correlates, and Prognosis. J Am Heart Assoc. 2018 Jun 01; 7(11). PMID: 29858363.

    Read at: PubMed
  • Published on 5/17/2018

    Enserro DM, Vasan RS, Xanthakis V. Twenty-Year Trends in the American Heart Association Cardiovascular Health Score and Impact on Subclinical and Clinical Cardiovascular Disease: The Framingham Offspring Study. J Am Heart Assoc. 2018 May 17; 7(11). PMID: 29773573.

    Read at: PubMed
  • Published on 5/3/2018

    Peterson LR, Xanthakis V, Duncan MS, Gross S, Friedrich N, Völzke H, Felix SB, Jiang H, Sidhu R, Nauck M, Jiang X, Ory DS, Dörr M, Vasan RS, Schaffer JE. Ceramide Remodeling and Risk of Cardiovascular Events and Mortality. J Am Heart Assoc. 2018 May 03; 7(10). PMID: 29728014.

    Read at: PubMed
  • Published on 3/7/2018

    Nayor M, Enserro DM, Xanthakis V, Larson MG, Benjamin EJ, Aragam J, Mitchell GF, Vasan RS. Comorbidities and Cardiometabolic Disease: Relationship With Longitudinal Changes in Diastolic Function. JACC Heart Fail. 2018 Apr; 6(4):317-325. PMID: 29525334.

    Read at: PubMed
  • Published on 2/1/2018

    Nayor M, Duncan MS, Musani SK, Xanthakis V, LaValley MP, Larson MG, Fox ER, Vasan RS. Incidence of cardiovascular disease in individuals affected by recent changes to US blood pressure treatment guidelines. J Hypertens. 2018 Feb; 36(2):436-443. PMID: 29084083.

    Read at: PubMed
  • Published on 11/18/2017

    Maas R, Xanthakis V, Göen T, Müller J, Schwedhelm E, Böger RH, Vasan RS. Plasma Nitrate and Incidence of Cardiovascular Disease and All-Cause Mortality in the Community: The Framingham Offspring Study. J Am Heart Assoc. 2017 11 18; 6(11). PMID: 29151027.

    Read at: PubMed
  • Published on 10/5/2017

    Vasan RS, Xanthakis V, Lyass A, Andersson C, Tsao C, Cheng S, Aragam J, Benjamin EJ, Larson MG. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades. JACC Cardiovasc Imaging. 2018 Jan; 11(1):1-11. PMID: 28917679.

    Read at: PubMed

View 58 more publications: View full profile at BUMC

View all profiles